AMPK activation: a therapeutic target for type 2 diabetes?

Kimberly A Coughlan, Rudy J Valentine, Neil B Ruderman, Asish K Saha Endocrinology and Diabetes, Department of Medicine, Boston University Medical Center, Boston, MA, USA Abstract: Type 2 diabetes (T2D) is a metabolic disease characterized by insulin resistance, β-cell dysfunction, and el...

Full description

Bibliographic Details
Main Authors: Coughlan KA, Valentine RJ, Ruderman NB, Saha AK
Format: Article
Language:English
Published: Dove Medical Press 2014-06-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Online Access:http://www.dovepress.com/ampk-activation-a-therapeutic-target-for-type-2-diabetes-a17323